Prasterone enanthate, also known as dehydroepiandrosterone enanthate, is a synthetic ester derivative of the endogenous steroid hormone dehydroepiandrosterone (DHEA). It is a prodrug designed for sustained release, where the enanthate ester moiety prolongs its activity in the body following intramuscular administration. Its primary application is in the field of endocrinology and gynecology. It has been investigated and used clinically for the treatment of conditions related to hormonal imbalance, such as menopausal symptoms and vulvovaginal atrophy. The compound acts as a precursor to both androgens and estrogens, exerting its effects through conversion to active sex hormones in peripheral tissues. As a steroid derivative with a specific chiral center and a long-chain fatty acid ester, it also serves as a key chiral intermediate in the synthesis of more complex steroid-based pharmaceuticals. Its handling requires standard precautions for steroid compounds.